Skip to main content
Caplight Logo









MexBrain

MexBrain

Private
VilleurbanneHealthcare & Life Scienceshttps://mexbrain.com/

Last Round

Series A

May 5, 2021

Total Funding Raised

$7.19M

Company Overview

MexBrain operates in Healthcare & Life Sciences and is based in Villeurbanne. Its latest recorded funding round was a Series A round in May 2021.

MexBrain is a biotechnology company that develops dialysis medical devices for the extraction of excess metals from the blood to treat conditions involving metal toxicity.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

MexBrain Comparables

Compare MexBrain with similar companies based on industry and business-model similarity.

MexBrain comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Invizius
72%
Baxter International Inc
62%
Toray Industries, Inc.
61%
Book a demo to see all comparables

For institutional investors. Book with your work email.

MexBrain Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 5, 2021
SeedOct 1, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

MexBrain Investors

Notable investors and investment history

MexBrain investors
InvestorRounds
Montpensier ArbevelSeries A
KreaxiSeries A
PulsalysSeed
AngelorSeries A
BpifranceSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 5, 2021

    $7M round led by Montpensier Arbevel

Book a demo to see all signals

For institutional investors. Book with your work email.

MexBrain Filings

Explore SEC and related filing metadata, where available.

MexBrain filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about MexBrain's valuation, stock price, and market status.

Is MexBrain a public or private company?

MexBrain is a private company.

What is the current stock price of MexBrain?

MexBrain is a private company, so its shares have no public market price. Caplight tracks MexBrain's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is MexBrain worth (valuation)?

Valuation information for MexBrain is not publicly available.

Can I buy MexBrain stock?

MexBrain shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was MexBrain's last funding round?

MexBrain's most recent funding round was Series A on May 5, 2021.

Who are the main investors in MexBrain?

Key investors in MexBrain include Montpensier Arbevel.

Will MexBrain IPO soon?

No public IPO plans have been announced for MexBrain.

How can I track MexBrain secondary market activity?

Caplight tracks bids, offers, and trades in MexBrain's shares on secondary markets.

Firmographic Details

HeadquartersVilleurbanne
Employee Range11
Year Founded2017
Last FundingMay 5, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?